| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
Redx Pharma appoints Peter Collum as CFO
StockMarketWire.com
|
Cancer and fibrosis focused Redx Pharma said it had appointed Peter Collum as its chief financial officer.
Collum was joining from Pharnext SA, an advanced late-stage clinical biopharmaceutical company, where he has been CFO since July 2019.
He also had been a partner at MTS Health Partners, a boutique healthcare investment bank in New York and worked in the healthcare investment banking group at Bank of America.
At 8:43am: (LON:REDX) Redx Pharma Plc share price was 0p at 62.5p
Story provided by StockMarketWire.com
|
|
|
|
|
|
